Mécanismes d'échappement tumoral à la réponse immunitaire
- 31 July 1999
- journal article
- abstracts
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 20 (7), 579-588
- https://doi.org/10.1016/s0248-8663(99)80107-6
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Apoptosis by Death FactorCell, 1997
- Cytokines, tumour-cell death and immunogenicity: a question of choiceImmunology Today, 1997
- Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein‐Barr virus latent membrane protein‐1: coordinate up‐regulation of peptide transporters and HLA‐class I antigen expressionEuropean Journal of Immunology, 1995
- CD28/CTLA-4 receptor structure, binding stoichiometry and aggregation during T-cell activationResearch in Immunology, 1995
- Vitiligo-like lesions following immunotherapy with IFNα and IL-2 in melanoma patientsEuropean Journal Of Cancer, 1994
- Molecular Mechanisms Used by Tumors to Escape Immune RecognitionJournal of Immunotherapy, 1993
- In search of the ‘missing self’: MHC molecules and NK cell recognitionImmunology Today, 1990
- Paraneoplastic night blindness with malignant melanoma1American Journal of Ophthalmology, 1988
- Malignant melanoma and vitiligo-like leukoderma: An electron microscopic studyJournal of the American Academy of Dermatology, 1983
- Vitiligo in patients with metastatic melanoma: A good prognostic signJournal of the American Academy of Dermatology, 1983